For Innovators and Researchers
The FDA has created a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). The program uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful.
The National Research Action Plan on Long COVID outlines research questions and topics of highest importance and with the greatest potential to yield early, safe, and effective benefit for people with Long COVID. Characterizing the Full Clinical Spectrum of Long COVID and Diagnostic Strategies, including:
- Surveillance and Epidemiology
- Long COVID and Overall Well-Being
- Therapeutics and Other Health Interventions
- Human Services, Supports, and Interventions
- Health Services and Health Economics Research
To support the development of services, supports and interventions for Long COVID and its associated conditions data collection is important.
National surveys that provide point-in-time data of Long COVID are detailed below. Their methods, timeline, data sources, and populations vary.